MedPath

Investigation of the effect of Samen-ista emulsion on the treatment of upper gastrointestinal non-bleeding visible vessel

Phase 3
Recruiting
Conditions
Diseases of esophagus, stomach and duodenum.
Acute gastric ulcer with hemorrhage
Registration Number
IRCT20140824018915N6
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients with upper gastrointestinal bleeding who refer to the emergency wards of Ghaem and Imam Reza hospitals with non-bleeding visible vessel during initial endoscopy

Exclusion Criteria

All types of bleeding except bleedings caused by a non-bleeding visible vessel
Pregnancy
Hemodynamic instability during endoscopy
Uncorrected coagulation disorders
Peptic ulcers that have undergone endoscopic treatment within the last 7 days
Thrombocytopenia less than 100,000
Kidney Failure (Creatinine> 1.5)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of complications (rebleeding). Timepoint: In the first 24 hours, patient will be placed under precise monitoring (checking vital signs investigation of rebleeding) every 4 hours and then, for investigation of ulcer, another endoscopy is performed. follow ups will be done after 72 hours in the hospital and through phone calls after a month. Method of measurement: Endoscopy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath